Glassesoff Inc. (GLSO) 3.5100 $GLSO GlassesOff Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Glassesoff Inc. (GLSO) 3.5100 $GLSO

GlassesOff Announces Positive Results From ADHD Study
PR Newswire - Mon May 04, 10:57AM CDT
GlassesOff Inc. (OTCBB: GLSO) announced today the results from a study in children and adults with attention deficit hyperactivity disorder (ADHD), demonstrating non-invasive, game-like technology that can provide an early indication of whether a child has ADHD and to what degree. In addition, once a child has been prescribed an ADHD medication, the GlassesOff tool may be able to be utilized as a monitor to provide insight as to whether the medication and/or its dosing are effective, or should be modified. GlassesOff intends to develop a dedicated ADHD commercial application following results of the study.

GlassesOff Announces Reverse Stock Split
PR Newswire - Mon Mar 30, 4:30PM CDT
GlassesOff Inc. (OTCBB: GLSO), a neuroscience technology company developing vision performance enhancement solutions through brain exercises, announced today it has implemented a 1-for-10 reverse split of its common stock effective under Nevada law as of March 30, 2015. GlassesOff's common stock will commence trading on a split-adjusted basis on March 31, 2015 under a new CUSIP number 377215207 and a temporary symbol "GLSOD," with the "D" appended to signify that the reverse stock split has occurred. GlassesOff's trading symbol will revert to "GLSO" after 20 trading days.

GlassesOff Launches First Localized Language Version of Its App for French-Speaking Markets
PR Newswire - Mon Mar 23, 7:00AM CDT
GlassesOff Inc. (OTCBB: GLSO) announced today the official launch of a localized language version of its app for French-speaking markets, which is available on both the iOS and Android platforms.

AeroScout Founder Joins GlassesOff's Board of Directors
PR Newswire - Mon Dec 15, 7:05AM CST
GlassesOff Inc. (OTCBB: GLSO) announced today the appointment of Mr. Yuval Bar-Gil as an independent director of the Company's Board of Directors.

New study shows 40% improvement in visual processing speed in young subjects with 20/20 vision, following use of a new technology by GlassesOff, potentially offering superior athletic performance in sports requiring swift reaction time
PR Newswire - Mon Dec 01, 7:08AM CST
GlassesOff Inc. (OTCBB: GLSO) announced today that new data recently published in Nature's Scientific Reports demonstrates the potential of GlassesOff to affect the performance of young professional and amateur athletes in sports requiring swift reaction time, such as tennis, baseball, football, ice hockey and others.

Recent Study Results Show Broad Potential For GlassesOff App
David Bautz - at Seeking Alpha - Mon Oct 27, 1:00PM CDT


A Study Commissioned by the Israeli Air Force, Using GlassesOff App, Shows Air Force Pilots Gain Significant Improvement in Visual Acuity, Image Processing Speed
PR Newswire - Mon Oct 20, 7:08AM CDT
GlassesOff Inc. (OTCBB: GLSO) today announced that statistically significant interim results from a study commissioned by the Israeli Air Force (IAF) demonstrated significant improvements in critical visual functions of IAF pilots through the use of the GlassesOff mobile app. The data will be presented today at the annual meeting of the American Academy of Ophthalmology. By using the GlassesOff mobile app, currently available on the App Store and Google Play, the IAF pilots in the study improved across multiple visual functions, including 35% improvement in visual acuity and 24% improvement in image processing speed.

GlassesOff Secures $15 Million Financing Facility
Business Wire - Thu Jul 03, 8:00AM CDT
GlassesOff Inc. (OTCBB:GLSO) a neuroscience technology company, today announced that is has secured a committed equity financing facility under which it may sell up to $15 million of its shares of common stock to YA Global Master SPV Ltd. over a period of up to 36-months. GlassesOff is not obligated to use the facility and remains free to enter into and consummate other financing transactions.

GlassesOff App Now Available for Android Devices
Business Wire - Mon Jun 30, 8:00AM CDT
GlassesOff Inc. (OTCBB: GLSO) a neuroscience technology company, today announced the release of its innovative mobile application GlassesOff(TM) for Android-operated devices. The GlassesOff(TM) product aims to eliminate the dependency on reading glasses of people over the age of 40 who experience natural age-related changes in their near vision sharpness. The GlassesOff(TM) product was soft- launched in December 2013 and was available to date solely on iOS operated devices market (iPhone/iPad/iPod).

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Rate and Betterment's Mortgage Play: Savings or Spin?

Updated Category News Views 151

So here’s the scoop: Rate just teamed up with Betterment on February 17, 2026, offering some pretty slick mortgage incentives for those sitting on at least $100K in their investment accounts. But let’s dig into the nitty-gritty before you start dreaming of that low-rate home loan. Betterment's Strategy: Solid Gains or Hype? The partnership aims to deliver discounted...

Continue Reading
UK Water Companies Gain Confidence After Regulatory Update

Updated Category News Views 253

Morgan Stanley Highlights UK Water Sector Improvements Investment risks surrounding listed UK water companies have significantly decreased following a key regulatory decision concerning water bill increases in England and Wales. According to analysts from Morgan Stanley, this development has created a more favorable landscape for investors in the sector. Key Insights From...

Continue Reading
SiLC Technologies Unveils Advanced Eyeonic Trace Scanner

Updated Category News Views 228

SiLC Technologies Introduces Eyeonic Trace Laser Line Scanner SiLC Technologies, a leader in the development of advanced integrated FMCW LiDAR solutions, recently announced an exciting new product: the Eyeonic Trace Laser Line Scanner. This state-of-the-art Class 1 Laser Line Scanner is engineered to achieve precise measurements of objects from distances of up to 10...

Continue Reading
Accord BioPharma Launches HERCESSI™ for Cancer Treatment

Updated Category News Views 94

Accord BioPharma Announces FDA Approval for HERCESSI™ Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, has achieved a major milestone in cancer treatment with the FDA's approval of a new 420mg strength of HERCESSI™ (trastuzumab-strf). This biosimilar to Herceptin (trastuzumab) targets different types of HER2-overexpressing cancers, such as...

Continue Reading
Why Oklo Stock is Soaring This Week and What to Expect

Updated Category News Views 493

What’s Driving Oklo Inc’s Stock Surge? Oklo Inc (NYSE: OKLO) is making waves in the stock market as its shares witness impressive growth. Over the past month, the company has experienced a remarkable rally of approximately 60%. Investors are keen to learn about the driving forces behind this upward trend. Recent Positive Developments This recent surge can primarily be...

Continue Reading